Replies to post #86870 on Biotech Values

[genisi]

I thought Teva would launch at-risk on July 2010. Either the market looks too small for the risk or ABT gave them something in return to the 8 months delay.

[genisi]

Under some circumstances, Teva may not receive rights to TriCor's 145-milligram dose until July 1, 2012.

During the call yesterday, Teva said its generic Tricor will not be launched in 2012 (no explanation was given).